Status:

RECRUITING

A Randomized Comparison Between 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg of Perineural Dexmedetomidine for Ultrasound-Guided Infraclavicular Block

Lead Sponsor:

McGill University Health Centre/Research Institute of the McGill University Health Centre

Conditions:

Analgesia

Pain, Acute

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

This study will compare three different doses of perineural dexmedetomidine 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg as adjuvants to local anesthetics for ultrasound-guided infraclavicular brachial plex...

Detailed Description

With the approval of Ethics Committee of the McGill University Health Centre, a total of 69 patients undergoing upper extremity surgery (elbow and below) will be recruited. Recruitment will be carried...

Eligibility Criteria

Inclusion Criteria:

  • patients undergoing upper limb surgery at or below the elbow
  • age between 18 and 75 years
  • American Society of Anesthesiologists classification 1-3
  • body mass index between 18 and 35 kg/m2

Exclusion Criteria:

  • adults who are unable to give their own consent
  • allergy or contraindication to dexmedetomidine
  • exposure to dexmedetomidine during the previous 48 hrs
  • pre-existing neuropathy (assessed by history and physical examination)
  • coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood workup i.e. platelets ≤ 100, International Normalized Ratio ≥ 1.4 or partial prothrombin time ≥ 50)
  • renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work-up i.e. creatinine. eGFR < 90)
  • hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work-up i.e. transaminases ≥ 100)
  • allergy to LA
  • pregnancy (as institutional policy, female patients with childbearing potential undergoing non urgent surgery are tested preoperatively for pregnancy with blood tests)
  • breast feeding
  • prior surgery in the infraclavicular region
  • chronic pain syndromes requiring opioid intake at home

Key Trial Info

Start Date :

December 28 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2026

Estimated Enrollment :

69 Patients enrolled

Trial Details

Trial ID

NCT07249827

Start Date

December 28 2025

End Date

June 30 2026

Last Update

January 7 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

McGill University Health Centre

Montreal, Quebec, Canada, H3G 1A4